<SEC-DOCUMENT>0000899140-19-000271-index.html : 20190228 <SEC-HEADER>0000899140-19-000271.hdr.sgml : 20190228 <ACCEPTANCE-DATETIME>20190228163605 ACCESSION NUMBER: 0000899140-19-000271 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190222 ITEM INFORMATION: Changes in Registrant's Certifying Accountant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20190228 DATE AS OF CHANGE: 20190228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Innoviva, Inc. CENTRAL INDEX KEY: 0001080014 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943265960 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-30319 FILM NUMBER: 19643930 BUSINESS ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 500 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 6502389600 MAIL ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 500 CITY: BRISBANE STATE: CA ZIP: 94005 FORMER COMPANY: FORMER CONFORMED NAME: THERAVANCE INC DATE OF NAME CHANGE: 20020207 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MEDICINE INC DATE OF NAME CHANGE: 20000302 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>i8k.htm <DESCRIPTION>FORM 8K <TEXT> Document 1 - file: i8k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-16.1 <SEQUENCE>2 <FILENAME>iex16_1.htm <DESCRIPTION>LETTER FROM ERNST & YOUNG LLP DATED FEBRUARY 28, 2019 <TEXT> Document 2 - file: iex16_1.htm
</DOCUMENT> </SEC-DOCUMENT>